Literature DB >> 10674496

TNF-alpha induced over-expression of GFAP is associated with MAPKs.

L Zhang1, W Zhao, B Li, D L Alkon, J L Barker, Y H Chang, M Wu, D R Rubinow.   

Abstract

Increased levels of tumor necrosis factor-alpha (TNF-alpha), a pluripotent cytokine that is reportedly mitogenic to astrocytes, are associated with the expression of glial fibrillary acidic protein (GFAP), the most specific marker for astrocytes, in many neuropathological conditions, including brain injury, CNS infection, Creutzfeldt-Jakob disease and Alzheimer's disease. Here, we show that treatment of cultured astrocytes with TNF-alpha resulted in dramatic over-expression of GFAP, associated with a substantial activation of the mitogen activated protein kinase (MAPK) Erk2 (extracellular signal-regulated protein kinase). We also demonstrate that TNF-alpha-induced over-expression of GFAP was significantly attenuated by the MAPK inhibitor PD98059. We conclude that TNF-alpha may upregulate GFAP through the MAPK signaling pathway. Because increased GFAP is a hallmark of reactive gliosis, understanding the mechanisms that regulate GFAP expression may facilitate development of strategies to minimize the gliosis associated with many brain diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10674496     DOI: 10.1097/00001756-200002070-00037

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

1.  TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer's disease.

Authors:  M M Edwards; S R Robinson
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

2.  Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection.

Authors:  Eleonora Tavazzi; David Morrison; Peter Sullivan; Susan Morgello; Tracy Fischer
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

3.  Chronic TNFα Exposure Induces Robust Proliferation of Olfactory Ensheathing Cells, but not Schwann Cells.

Authors:  Karen L Lankford; Edgardo J Arroyo; Jeffery D Kocsis
Journal:  Neurochem Res       Date:  2017-05-11       Impact factor: 3.996

4.  Dysregulation of mitogen-activated protein kinase signaling pathways in simian immunodeficiency virus encephalitis.

Authors:  Sheila A Barber; Jennifer L Uhrlaub; Jesse B DeWitt; Patrick M Tarwater; M Christine Zink
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

5.  Separate sequences in a murine retroviral envelope protein mediate neuropathogenesis by complementary mechanisms with differing requirements for tumor necrosis factor alpha.

Authors:  Karin E Peterson; Scott Hughes; Derek E Dimcheff; Kathy Wehrly; Bruce Chesebro
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  Sleep Disruption Exacerbates and Prolongs the Inflammatory Response to Traumatic Brain Injury.

Authors:  Zoe M Tapp; Julia E Kumar; Kristina G Witcher; Ravitej R Atluri; John A Velasquez; Shane M O'Neil; Julia E Dziabis; Chelsea E Bray; John F Sheridan; Jonathan P Godbout; Olga N Kokiko-Cochran
Journal:  J Neurotrauma       Date:  2020-04-21       Impact factor: 5.269

7.  Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation.

Authors:  Christiane Albert-Weissenberger; Christian Stetter; Sven G Meuth; Kerstin Göbel; Michael Bader; Anna-Leena Sirén; Christoph Kleinschnitz
Journal:  J Cereb Blood Flow Metab       Date:  2012-05-09       Impact factor: 6.200

Review 8.  HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads.

Authors:  Kathleen Borgmann; Anuja Ghorpade
Journal:  Front Microbiol       Date:  2015-10-27       Impact factor: 5.640

Review 9.  Mechanisms underlying dental-derived stem cell-mediated neurorestoration in neurodegenerative disorders.

Authors:  Syed Shadab Raza; Aurel Popa Wagner; Yawer S Hussain; Mohsin Ali Khan
Journal:  Stem Cell Res Ther       Date:  2018-09-26       Impact factor: 6.832

10.  Oral Selumetinib Does Not Negatively Impact Photoreceptor Survival in Murine Experimental Retinal Detachment.

Authors:  Colleen M Cebulla; Bongsu Kim; Valerie George; Tyler Heisler-Taylor; Sumaya Hamadmad; Alana Y Reese; Shaili S Kothari; Rania Kusibati; Hailey Wilson; Mohamed H Abdel-Rahman
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-01-02       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.